Qibin Zhang, PhD, is an Associate Professor in the Department of Chemistry and Biochemistry, and Co-Director of the Center for Translational Biomedical Research at the University of North Carolina at Greensboro (UNCG), North Carolina, U.S.A. He obtained his PhD degree from the University of California at Riverside, followed by postdoctoral studies in proteomics and metabolomics at the Pacific Northwest National Laboratory (PNNL), U.S. Department of Energy. He started his independent research career at PNNL as a Scientist and moved to the current position in 2014.
With multiple grants support from the National Institutes of Health and the American Heart Association, the Zhang lab is focused on development of advanced mass spectrometric analysis tools and clinical applications of proteomics, lipidomics and metabolomics. The primary research interests are in protein and lipid biomarkers of Type 1 Diabetes and cardiovascular diseases resulted from diabetic complications. In addition to developing tools for lipidomics and intact analysis of glycosphingolipids, his team reported the most comprehensive temporal changes of human plasma proteins during childhood and development of T1D, which revealed that systemic dysregulation of innate immunity and oxidative stress are hall marks at early stages of T1D.
Dr. Zhang is a co-recipient of a Collaborative Sciences Award from the AHA.
Abstracts this author is presenting: